Steve McPhail, President & Chief Executive Officer

BS Biology - San Diego State University
Steve has spent his career serving companies in the diagnostic, biotechnology and medical device markets. He previously acted as executive vice president and COO of ArgoMed, Inc.  Earlier, Steve held senior level sales, marketing and business development positions for Xanthon, TriPath Imaging, Dynex Technologies and Abbott Laboratories. He has extensive experience in executing mergers and acquisitions, developing strategic marketing plans, and establishing global distribution networks.  He serves on the board of the NC Children's Hospital and the Pediatric Inflammatory Bowel Disease Network.

Dr. Tom Goralski, Senior Vice President, Laboratory Operations

PhD Molecular, Cellular & Dev. Biology Indiana University, Bloomington

Tom's expertise is in the areas of high throughput process development, quality control monitoring, microarray systems, and laboratory management. Prior to Expression Analysis, Tom was Director of Production Biology at Perlegen Sciences where he managed the team of scientists that identified over one million human single nucleotide polymorphisms employing re-sequencing by hybridization to high-density, whole-wafer microarray technology developed at Affymetrix. Tom also held positions in DNA sequencing and microarray operations at Incyte Genomics.

Dr. Wendell Jones, Vice President, Statistics & Bioinformatics

PhD Statistics - Clemson University

Wendell is a consulting statistician and thought leader in industry.  His interests are bioinformatics, statistical modeling, statistical graphics, and analyzing large datasets.  Wendell has been a lead participant in the Microarray Quality Control (MAQC) project and is co-chair of the Clinical Working Group in MAQC Phase II, examining the capabilities of microarrays for predicting outcomes in complex diseases.  Wendell supports student research in biology and genetics as a faculty adjunct within the School of Medicine at University of North Carolina at Chapel Hill.

Eric Setzer,  MBA - Chief Financial Officer

MBA – Duke University, The Fuqua School of Business

Eric has more than fifteen years of hands-on experience with the operational and financial challenges faced by growing technology and life science companies.  His background includes general management, mergers and acquisitions, debt and equity financings, initial public offerings, private placements and business strategy.  Eric was previously Chief Financial Officer of Kolis Scientific, a Research Triangle Park medical device start-up.  Earlier, he was Chief Financial Officer of two separate venture capital funded start up companies in the health care technology sector.

Karen Michailo, Director of Marketing

JD - Western State College of Law

Karen has spent a majority of her career in senior level marketing positions for diverse organizations in varied industries. For a number of years, Karen worked with life science and biotechnology firms, specializing in the planning and implementation of marketing initiatives on their behalf. 

Nichole Martin, MSQA, CQA, CMQ/OE- Senior Manager Quality Systems

 BS in Biochemistry and minor in Genetics from North Carolina State University

Nichole worked as a cytogenetics technologist for several years with a diagnostics company in RTP prior to beginning her career in quality in the plasma-derived pharmaceutical industry. She is a senior member of the American Society for Quality and is a Certified Quality Auditor and Manager of Quality/Organizational Excellence. She has also successfully completed a Master’s Degree in Quality Assurance program from California State University, Dominguez Hills with her culminating thesis discussing the relationship between personal and professional quality.